These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3010223)

  • 21. Comparison of the binding of gram-negative bacterial endotoxin by polymyxin B sulphate, colistin sulphate and colistin sulphomethate sodium.
    Rogers MJ; Cohen J
    Infection; 1986; 14(2):79-81. PubMed ID: 3011678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-CD11b monoclonal antibody in an infant rat model of Haemophilus influenzae type b sepsis and meningitis.
    Tan TQ; Smith CW; Hawkins EP; Kaplan SL
    J Antimicrob Chemother; 1997 Feb; 39(2):209-16. PubMed ID: 9069541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymyxin B moderates acidosis and hypotension in established, experimental gram-negative septicemia.
    Flynn PM; Shenep JL; Stokes DC; Fairclough D; Hildner WK
    J Infect Dis; 1987 Nov; 156(5):706-12. PubMed ID: 2821123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pertussis toxin on susceptibility of infant rats to Haemophilus influenzae type b.
    Samore MH; Siber GR
    J Infect Dis; 1992 May; 165(5):945-8. PubMed ID: 1533239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasion of the inner ear by Haemophilus influenzae type b in experimental meningitis.
    Kaplan SL; Hawkins EP; Kline MW; Patrick GS; Mason EO
    J Infect Dis; 1989 May; 159(5):923-30. PubMed ID: 2523431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of endotoxemia in burn patients by use of polymyxin B.
    Munster AM; Xiao GX; Guo Y; Wong LA; Winchurch RA
    J Burn Care Rehabil; 1989; 10(4):327-30. PubMed ID: 2551907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific detection of Haemophilus influenzae type b lipooligosaccharide by a polymyxin B monoclonal antibody assay.
    Mertsola J; Ramilo O; Sáez-Llorens X; Hanson MS; McCracken GH; Hansen EJ
    J Immunol Methods; 1989 Sep; 122(2):219-26. PubMed ID: 2551967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspects of the pathogenicity of some oral and other haemophili.
    Tuyau JE; Sims W
    J Med Microbiol; 1983 Nov; 16(4):467-75. PubMed ID: 6644787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enteric coated polymyxin B in the treatment of hyperammonemia and endotoxemia in liver cirrhosis.
    Adachi Y; Enomoto M; Adachi M; Suwa M; Nagamine Y; Nanno T; Hashimoto T; Inoue H; Yamamoto T
    Gastroenterol Jpn; 1982 Dec; 17(6):550-7. PubMed ID: 6298048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of postburn immunosuppression with low-dose polymyxin B.
    Munster AM; Winchurch RA; Thupari JN; Ernst CB
    J Trauma; 1986 Nov; 26(11):995-8. PubMed ID: 2878088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymyxin B sulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin.
    Hughes B; Madan BR; Parratt JR
    Br J Pharmacol; 1981 Nov; 74(3):701-7. PubMed ID: 6170378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of polymyxin B sulfate in experimental enterobacterial infection in mice.
    Bannatyne RM; Cheung R
    Can J Microbiol; 1979 Sep; 25(9):995-8. PubMed ID: 232006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo effect of polymyxin B on pertussis vaccine.
    Larter WE; Corrigan JJ; Fulginiti VA
    Am J Dis Child; 1984 Mar; 138(3):281-3. PubMed ID: 6322572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymyxin B inactivation of lipopolysaccharide in vaccines of Gram-negative bacteria.
    Cooperstock M; Riegle L
    Infect Immun; 1981 Jul; 33(1):315-8. PubMed ID: 6266967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock.
    Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Paggi AM; Orlando F; Kamysz W; Kasprzykowski F; Mackiewicz Z; Scalise G; Saba V
    J Antimicrob Chemother; 2002 Jan; 49(1):193-6. PubMed ID: 11751788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of low-dose polymyxin B on hemorrhage-induced endotoxin/bacterial translocation and cytokine formation in rats.
    Yao YM; Tian HM; Sheng ZY; Wang YP; Yu Y; Sun SR; Xu SH
    J Trauma; 1995 Jun; 38(6):924-30. PubMed ID: 7602637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of the generalized Shwartzman reaction and endotoxin lethality by polymyxin B localized in tissues.
    Craig WA; Turner JH; Kunin CM
    Infect Immun; 1974 Aug; 10(2):287-92. PubMed ID: 4369040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymyxin B in gram-negative septicemia.
    Bannatyne RM
    J Infect Dis; 1988 Jun; 157(6):1279. PubMed ID: 2836524
    [No Abstract]   [Full Text] [Related]  

  • 39. Polymyxin B suppresses the endotoxin inhibition of concanavalin a-mediated erythrocyte agglutination.
    Warren JR
    Infect Immun; 1982 Feb; 35(2):594-9. PubMed ID: 6276306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymyxin B use does not ensure endotoxin-free solution.
    Kluger MJ; Singer R; Eiger SM
    J Immunol Methods; 1985 Oct; 83(1):201-7. PubMed ID: 2997328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.